We argue against selling Geron at current prices, citing strong market potential of imetelstat and Royalty Pharma deal ...

BofA raised the firm’s price target on Argenx (ARGX) to $774 from $770 and keeps a Buy rating on the shares. The company pre-announced Q4 ...

We recently published a list of the 10 Best Cancer Stocks to Buy According to Hedge Funds. In this article, we are going to ...

Shares of Biogen Inc. BIIB slid 1.10% to $142.34 Monday, on what proved to be an all-around dismal trading session for the stock market, with the S&P 500 Index SPX falling 0.76% to 5,994.57 and Dow ...

(Reuters) - Regeneron Pharmaceuticals beat fourth-quarter sales and profit estimates on Tuesday, on continuing demand for its eczema treatment, Dupixent, and announced a dividend and stock buyback ...

Precision medicine is revolutionizing healthcare, and these genomic stocks are leading the way. Therefore, as this sector ...

Pharmaceuticals, a leading biotechnology company with a market capitalization of $71.75 billion, has been navigating a complex landscape of opportunities and challenges in recent months. According to ...

Liberty Media Corp. Series C Liberty Formula One 0.00% $30.12B Liberty Media Corp. Series A Liberty Formula One 0.30% $30.12B Liberty Broadband Corp. Cl A-0.83% $10.97B Liberty Broadband Corp. Cl ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

This is 3x the increase of the Dow Index during this period. Is the price of gold too volatile for the average investor? Gold is no more volatile than the stock market. Gold prices can have sudden ups ...

RBC Capital analyst Gordon Ramsay CFA maintained a Buy rating on Origin Energy Limited (OGFGF – Research Report) on January 31 and set a price ...

Biotech company Regeneron (NASDAQ:REGN) reported Q4 CY2024 results , with sales up 10.3% year on year to $3.79 billion. Its ...